PharmaEssentia and FORUS Therapeutics Partner to Commercialize BESREMi

PharmaEssentia Corporation, a biopharmaceutical company from Taiwan, using expertise and scientific principles, will distribute BESREMi in Canada for treating polycythemia vera through an exclusive licensing agreement with FORUS Therapeutics Inc...

HealthPlix transforms healthcare with AI for doctor-patient conversations

HealthPlix Technologies, the biggest AI-driven EMR software provider in India, introduced HALO, an inventive solution aimed at modernizing healthcare by converting doctor-patient interactions into digital prescriptions...

Nxera Pharma To Receive USD $35 Million from Neurocrine Biosciences

Nxera Pharma Co., Ltd. is set to get a US$35 million payout from Neurocrine Biosciences (‘Neurocrine’) for the Phase 2 trial success with NBI-1117568 (NBI-‘568) in adults with schizophrenia, as disclosed on 28 August 2024. Recognition of the US$35...

Indian Pharma Sector To play a crucial role in Global Market

The Indian pharmaceutical sector is set to bolster its position in the global market, said K Raja Bhanu, director general of the Pharmaceuticals Export Promotion Council of India (Pharmexcil). During the closing day of iPHEX 2024, Bhanu emphasized...

Sunfox Bags Rs 15 crore in Pre-series Funding For Cardiac Innovations

Sunfox Technologies, the health tech startup known for its participation on Shark Tank India, has secured an extra Rs 15 crore in a pre-series funding phase. Existing investor Venture Catalyst led the round, with new investors including Finvolve...

Shilpa Medicare Concludes phase 1 trial for volume replacement therapy

Shilpa Medicare has effectively finished its phase 1 clinical trial for its leading product, sRbumin, a recombinant human albumin 20% (rHA). Human serum albumin is crucial for different medical interventions, including fluid replacement therapy...

Pharma Manufacturing & Automation Excellence Awards 2024: Honoring The Visionaries Behind Pharma's Transformational Growth

Driven by global demand, generics production, and increased domestic investment, India's pharma manufacturing sector has grown by 9% to 12% annually over the past two years. Automation in the industry has also surged, with 15% to 18% annual growth.

6th Annual Pharma Manufacturing & Automation Convention 2024

The pharma industry is undergoing a transformative evolution with the integration of advanced manufacturing technologies and automation systems. In the 2-day program 6th Annual Pharma Manufacturing and Automation Convention 2024.

US FDA Nods SmartAdjust technology for Individuals with type 2 Diabetes

The FDA broadened the uses of Insulet SmartAdjust, a technology for diabetes management, to include type 2 diabetes in adults over 18 years old, in addition to type 1 diabetes in individuals aged two and older. Software that automatically adjusts...

Bharat Biotech to Globally Market its Oral Cholera Vaccine

On Tuesday, Bharat Biotech announced that its oral cholera vaccine has successfully completed a late-stage trial and is preparing for a global launch, with plans to produce up to 200 million doses annually. The vaccine, named Hillchol, has receive...

© 2024 India Pharma Outlook. All Rights Reserved.